European Society for Medical Oncology (ESMO) shared a post on LinkedIn:
“As approved novel cancer therapies continue to expand across oncology, so does the need for practical guidance on how to use them – and how to manage the toxicities they bring.
ESMO Novel Cancer Therapies 2027 will offer a focused programme in Lugano, 8-10 March 2027, designed to support confident, real-world clinical decision-making through expert insight, multidisciplinary discussion and clinical cases.
Registration will open soon – save the date now and start planning to join us.”
Other articles about ESMO on OncoDaily.